Skip to main content

Day: September 17, 2021

Major Precious Metals Completes Over 8,400m Resource Definition Program at Skaergaard

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce that it has successfully completed its Phase 1 diamond drilling program at its Skaergaard Project (“Skaergaard”) in Greenland with all planned drill hole depths covering an area of approximately 10 km² within the 7.5 km (east-west) by 11 km (north-south) Skaergaard intrusion, including key new target zones in the northern part of the Project. HighlightsA total of 32 diamond drill holes (8,195 m) were completed in several key target areas in the northern part of Skaergaard. These target areas were discussed in the Company’s August 26, 2021 news release. Approximately 240 m of channel samples were also collected from four separate areas...

Continue reading

Nokia and Indosat Ooredoo launch 5G network in Indonesia

Written by Customer Service on . Posted in Public Companies.

Press Release Nokia and Indosat Ooredoo launch 5G network in IndonesiaNokia’s latest 5G AirScale portfolio to be deployed across Indonesia’s central islands delivering incredible 5G experiences to subscribers Nokia and Indosat Ooredoo together with Sepuluh Nopember Institute of Technology (ITS) and the University of Oulu to launch the Nokia 5G Experience Center providing a platform for the development of innovative new use cases by local digital talent17 September 2021 Espoo, Finland – Nokia and Indosat Ooredoo today announced the launch of commercial 5G services in Surabaya city, Indonesia. Under the deal, Indosat Ooredoo’s customers will experience new enterprise and industrial use cases underpinned by the new 5G network. Nokia will supply equipment from its latest ReefShark based AirScale product range, including its AirScale...

Continue reading

Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma

Written by Customer Service on . Posted in Public Companies.

– Interim results to be presented September 17 at the European Society for Medical Oncology (ESMO) Congress 2021 – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with ESCC – – Coherus and Junshi Biosciences plan to submit a BLA supplement for 1L ESCC in 2022 – SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced positive interim results from the pivotal study “JUPITER-06” (NCT03829969), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab in combination with chemotherapy as a first-line therapy for patients with advanced or metastatic esophageal squamous cell carcinoma...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.